Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,563.08
(
0.57%
)
US TECH 100
29,415.60
(
0.81%
)
Dow Jones
50,647.69
(
0.01%
)
Brent Oil
93.07
(
0.68%
)
Bitcoin
73,347.19
(
-2.05%
)
News Focus
News Focus
Post# of 57987
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123032
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: atheroprevent post# 32644

Monday, 03/15/2010 10:13:26 AM

Monday, March 15, 2010 10:13:26 AM

Post# of 57987

…the Accord trial tarnished 2 Novartis drugs…

The outcome won’t have a material impact for NVS, however. Diovan is going off-patent soon, and Starlix has never amounted to anything anyhow.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today